SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013263
Filing Date
2020-11-09
Accepted
2020-11-09 08:29:31
Documents
54
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ruby-20200930x10q.htm   iXBRL 10-Q 2065457
2 EX-31.1 ruby-20200930xex31d1.htm EX-31.1 11892
3 EX-31.2 ruby-20200930xex31d2.htm EX-31.2 12816
4 EX-32.1 ruby-20200930xex32d1.htm EX-32.1 7224
5 EX-32.2 ruby-20200930xex32d2.htm EX-32.2 7205
  Complete submission text file 0001558370-20-013263.txt   5665875

Data Files

Seq Description Document Type Size
6 EX-101.SCH ruby-20200930.xsd EX-101.SCH 31649
7 EX-101.CAL ruby-20200930_cal.xml EX-101.CAL 41852
8 EX-101.DEF ruby-20200930_def.xml EX-101.DEF 91297
9 EX-101.LAB ruby-20200930_lab.xml EX-101.LAB 326583
10 EX-101.PRE ruby-20200930_pre.xml EX-101.PRE 218403
11 EXTRACTED XBRL INSTANCE DOCUMENT ruby-20200930x10q_htm.xml XML 788370
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38586 | Film No.: 201296242
SIC: 2836 Biological Products, (No Diagnostic Substances)